NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
34.83
-0.34 (-0.97%)
At close: Jul 2, 2026, 4:00 PM EDT
34.15
-0.68 (-1.95%)
After-hours: Jul 2, 2026, 7:10 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $4.07 billion as of July 2, 2026. Its market cap has increased by 96.15% in one year.
Market Cap
4.07B
Enterprise Value
3.36B
1-Year Change
96.15%
Ranking
Category
Stock Price
$34.83
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.07B, an increase of 2,536.31%. That is a compound annual growth rate of 83.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.07B | 2.36% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.35B |
| Tango Therapeutics | 4.26B |
| Edgewise Therapeutics | 4.26B |
| Denali Therapeutics | 4.10B |
| Relay Therapeutics | 4.06B |
| Telix Pharmaceuticals | 4.04B |
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |